| Wendie Malkinski, NURSE PRACTITIONER | |
|
232 Dale Rd, Pasadena, MD 21122-2931 | |
| (443) 668-4300 | |
| Not Available |
| Full Name | Wendie Malkinski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 232 Dale Rd, Pasadena, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922216480 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | R-179131 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Psychnp Wellness Center Llc | 5890919625 | 9 |
News Archive
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
With new funding from The Mayday Fund, a Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy, endometriosis, interstitial cystitis and vulvodynia.
"Congress has ... blocked $200 million in aid to the Palestinian Authority [PA] since August, in a move a PA official described as 'collective punishment' for its United Nations bid" for statehood, GlobalPost reports.
New proposals to protect children and young people from tobacco-related harm have been unveiled by the Welsh Assembly government.
CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.
› Verified 4 days ago
| Entity Name | Psychnp Wellness Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184042004 PECOS PAC ID: 5890919625 Enrollment ID: O20140617000765 |
News Archive
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
With new funding from The Mayday Fund, a Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy, endometriosis, interstitial cystitis and vulvodynia.
"Congress has ... blocked $200 million in aid to the Palestinian Authority [PA] since August, in a move a PA official described as 'collective punishment' for its United Nations bid" for statehood, GlobalPost reports.
New proposals to protect children and young people from tobacco-related harm have been unveiled by the Welsh Assembly government.
CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendie Malkinski, NURSE PRACTITIONER 232 Dale Rd, Pasadena, MD 21122-2931 Ph: () - | Wendie Malkinski, NURSE PRACTITIONER 232 Dale Rd, Pasadena, MD 21122-2931 Ph: (443) 668-4300 |
News Archive
Epeius Biotechnologies (www.epeiusbiotech.com) announces the completion of the design engineering and construction phase of a state-of-the-art Vector Production Unit (VPU) for the commercial manufacturing of its advanced targeted genetic medicines. In accordance with an FDA Critical Path initiative, which encourages innovation and the implementation of new technological advances in GMP, CMC, aseptic processing, and quality control, the Epeius VPU is poised to launch the large-scale production of targeted genetic medicine into the 21st century.
With new funding from The Mayday Fund, a Saint Louis University researcher will leverage her discovery of a pain pathway to determine if either of two key molecules can be used as biomarkers for pain associated with four debilitating health conditions: chemotherapy-induced peripheral neuropathy, endometriosis, interstitial cystitis and vulvodynia.
"Congress has ... blocked $200 million in aid to the Palestinian Authority [PA] since August, in a move a PA official described as 'collective punishment' for its United Nations bid" for statehood, GlobalPost reports.
New proposals to protect children and young people from tobacco-related harm have been unveiled by the Welsh Assembly government.
CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.
› Verified 4 days ago
Dr. Milan Sanghavi, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8021 Ritchie Highway, Pasadena, MD 21122 Phone: 410-590-4616 Fax: 410-590-4619 |